Moisand Fitzgerald Tamayo’s Bio-Techne TECH Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28	Closed	-$1.91K	–	811
2023 Q3	$1.91K	Hold	28	–	–	﹤0.01%	572
2023 Q2	$2.29K	Hold	28	–	–	﹤0.01%	526
2023 Q1	$2.08K	Hold	28	–	–	﹤0.01%	549
2022 Q4	$2.32K	Buy	28 +12	+75%	+$953	﹤0.01%	528
2022 Q3	$1K	Buy	+16	New	+$1.38K	﹤0.01%	659

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Moisand Fitzgerald Tamayo's TECH Position: Q4 2023 in Review

Moisand Fitzgerald Tamayo sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 28 shares — an estimated $1.91K sold.

Moisand Fitzgerald Tamayo first reported a position in TECH in Q3 2022 and held it in 5 quarters. The position peaked at $2.32K in Q4 2022. 530 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Moisand Fitzgerald Tamayo reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
Moisand Fitzgerald Tamayo sold 28 Bio-Techne shares in Q4 2023, an estimated $1.91K.
Moisand Fitzgerald Tamayo first reported a position in Bio-Techne in Q3 2022 and held it in 5 quarters.
Moisand Fitzgerald Tamayo's Bio-Techne position peaked at $2.32K in Q4 2022.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q4 2023, filed 18 Jan 2024.